NCT Number: NCT00279968
INSIGHTS ICD Registry
The purpose of the Registry is to collect data on how Implantable Cardioverter Defibrillator (ICD) therapies and medications are being used by physicians to treat ventricular arrhythmias in order to better understand how to improve the clinical care of patients and effectiveness of ICD therapies.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Little Rock, Arkansas, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients 18 years of age or older.
- Patients or legal guardians who are willing and able to sign a Permission for Access to and Use of Health Information in a Registry Form and, if required by an Institution's IRB, an Informed Consent.
- New or replacement implants of Medtronic market released single, dual or triple chamber ICDs including: GEM VR, GEM DR, GEM III AT, Marquis VR, Marquis DR, Maximo DR, Maximo VR, InSync ICD, InSync Marquis ICD and InSync II Marquis ICD.
Exclusion criteria
- Patients enrolled in a device study which effects programming and or treatment.
Treatment and study plan
Sponsors and collaborators
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Industry
Collaborators
- Medtronic
Registry information
Official study title
Investigating Significant ICD Heart Therapies Registry Study (INSIGHTS ICD Registry)
Important dates
- Study start
- 2004
- Study completion
- 2006
- First posted
- Jan 20, 2006
- Registry last updated
- Dec 28, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Arrhythmias in Post-Myocardial Infarction Patients
NCT03231826
Arrhythmias, Cardiac, Arrythmia
Tampere, Pirkanmaa, Finland
View Trial DetailsDATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study
NCT00157820
Arrhythmias, Cardiac, Atrial Fibrillation
View Trial DetailsUnderstanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
NCT02433379
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Birmingham, Alabama, United States
View Trial DetailsSD01 Registry (SD01 ICD Lead)
NCT02014675
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Berlin, Germany
View Trial Details